Battle Against Drug Addiction Must Be Waged From Better Financed Laboratories

The "war on drugs" will not be won in the jungles of Colombia or along the borders of the United States. Drug abuse will come under control when we, as scientists, find ways to relieve addicts of their compulsive need for a fix. Addictions are chronic diseases originating in adolescence and young adulthood. Although the decision to experiment with drugs may have been voluntary, what occurs thereafter is a physiological disorder, not a "failure of will." Susceptibility to addiction is an inhere

Written byStanley Korenman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The "war on drugs" will not be won in the jungles of Colombia or along the borders of the United States. Drug abuse will come under control when we, as scientists, find ways to relieve addicts of their compulsive need for a fix.

Addictions are chronic diseases originating in adolescence and young adulthood. Although the decision to experiment with drugs may have been voluntary, what occurs thereafter is a physiological disorder, not a "failure of will." Susceptibility to addiction is an inherent characteristic that has been demonstrated in every species of animal tested. In humans, for example, cocaine activates the brain's intrinsic reward system, initially producing an intense sense of pleasure, a "high." It also acts as a reinforcer - an inducer of long-term memory - that creates a neurobehavioral demand for cocaine, resulting in "drug-seeking behavior." The reinforcing properties of crack (a smokable and quickly absorbed form of cocaine) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies